Job Description
Granada, Spain Call4Entrepreneurs - The Collider
About the job CEO ENDOMET (The Collider Programme)
ENDOMET | Switching On Endogenous Energy
CEO & Co-Founder Opportunity | Biotech | Rare Diseases & Womens Health
Are you looking for a high-impact entrepreneurial opportunity to build a science-driven biotech spin-off addressing rare mitochondrial diseases and female reproductive health?
ENDOMET, a deep-tech biotech project backed by the University of Granada, is developing MVP11, a first-in-class small molecule that restores mitochondrial energy by activating endogenous Coenzyme Q (CoQ) biosynthesis. The project is seeking an entrepreneurial CEO to join the founding team and lead the creation of the spin-off.
About ENDOMET
A large number of frequent and rare diseases are characterized by CoQ deficiency, leading to impaired mitochondrial energy production.
Current standard care relies on ex...